earnings
AA
NASDAQ · AARD
Aardvark Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$0.92
Down-$0.08 (-7.74%)
Updated Nov 22, 2026, 8:00 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 271.95M
- P/E ratio
- -5.56
- Dividend yield
- 0.00%
- 52-week range
- $0.90 – $16.60
- Volume
- 241.08K
- Avg. volume
- 188.95K
Price performance · AARD
AARD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 20, 2026
AARD closed at $0.92 after 20 trading sessions, down 14.57% for the selected period.
- Last close
- $0.92
- Period change
- -14.57%
- Period low
- $0.91
- Period high
- $1.59
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | $1.00 | $1.06 | $0.90 | $0.9226 | 241.08K |
| Nov 19, 2026 | $0.96 | $1.10 | $0.95 | $1.00 | 486.55K |
| Nov 18, 2026 | $1.16 | $1.21 | $0.9062 | $0.91 | 530.04K |
| Nov 17, 2026 | $1.24 | $1.3799 | $1.10 | $1.15 | 475.5K |
| Nov 16, 2026 | $1.33 | $1.48 | $1.21 | $1.26 | 215.22K |
| Nov 13, 2026 | $1.58 | $1.70 | $1.31 | $1.33 | 403.06K |
| Nov 12, 2026 | $1.58 | $1.615 | $1.51 | $1.52 | 249.8K |
| Nov 11, 2026 | $1.35 | $1.6799 | $1.34 | $1.59 | 388.41K |
| Nov 10, 2026 | $1.32 | $1.4399 | $1.29 | $1.37 | 242.69K |
| Nov 9, 2026 | $1.21 | $1.42 | $1.1705 | $1.35 | 686.07K |
| Nov 6, 2026 | $1.10 | $1.18 | $1.09 | $1.17 | 221.84K |
| Nov 5, 2026 | $1.18 | $1.2312 | $1.095 | $1.11 | 375.89K |
| Nov 4, 2026 | $1.25 | $1.28 | $1.169 | $1.26 | 216.5K |
| Nov 3, 2026 | $1.22 | $1.29 | $1.21 | $1.23 | 267.93K |
| Nov 2, 2026 | $1.37 | $1.396 | $1.20 | $1.20 | 345.53K |
| Oct 30, 2026 | $1.39 | $1.46 | $1.33 | $1.36 | 467.6K |
| Oct 29, 2026 | $1.48 | $1.53 | $1.3618 | $1.44 | 955.89K |
| Oct 28, 2026 | $1.22 | $1.59 | $1.1756 | $1.51 | 2.03M |
| Oct 27, 2026 | $1.09 | $1.39 | $1.09 | $1.30 | 4.28M |
| Oct 26, 2026 | $1.245 | $1.39 | $0.93 | $1.08 | 4.96M |
Latest AARD news
The latest Smart Investors Daily articles mentioning AARD.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

